Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in North Palm Beach, FL
NPI: 1457351934Primary Practice Location
Laszlo J. Mate, M.D., P.A.
824 US-1, North Palm Beach, FL
Primary Employer
Laszlo J. Mate, M.D., P.A.
matemd.com
HQ Phone
Get M.D. Laszlo's Phone NumberMobile
Get M.D. Laszlo's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1990 - 2026
CA State Medical License
1988 - 2023
OK State Medical License
1987 - 1989
American Board of Psychiatry and Neurology
Neurology with Special Qualification in Child Neurology
University Of Louisville School Of Medicine
louisville.edu
Residency • Pediatrics
1985 - 1987
Loma Linda University Health Education Consortium
Fellowship • Child Neurology
1988 - 1990
University of California (San Diego) Medical Center
Residency • Neurology
1987 - 1988
Semmelweis University
Medical School
Until 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 59 | 119 |
| 2 | 95819Measurement and recording of brain wave (EEG) activity, awake and asleep | 22 | 24 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep.
Authors: Maté, L, Virkel, G, Lifschitz, A, Sallovitz, J, Ballent, M, Lanusse, C
Journal: J Vet Pharmacol Ther
Regulation of gastric acid secretion by secretin and serotonin.
Authors: Mate, L, Sakamoto, T, Greeley, G H, Thompson, J C
Journal: Am J Surg
Authors: Ballent, M, Maté, L, Virkel, G, Sallovitz, J, Viviani, P, Lanusse, C, Lifschitz, A
Journal: J Vet Pharmacol Ther
Publication Date: 2014-03-10
Lead Sponsor: Avanir Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: AVP-923-45, DRUG: AVP-923-30, DRUG: AVP-923-20
Lead Sponsor: Ipsen
Intervention / Treatment: BIOLOGICAL: Botulinum toxin type A
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab
